Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network

BACKGROUND: Remarkably, the anti-cancer efficacy of immunotherapy in lung adenocarcinoma (LUAD) has been demonstrated. However, predicting the beneficiaries of this expensive treatment is still a challenge. MATERIALS AND METHODS: A group of patients (N = 250) diagnosed with LUAD and receiving immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Fu, Siyun, Gao, Xiang, Lu, Zhendong, Jin, Renjing, Qin, Na, Zhang, Xinyong, Wu, Yuhua, Li, Weiying, Wang, Jinghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086240/
https://www.ncbi.nlm.nih.gov/pubmed/37056768
http://dx.doi.org/10.3389/fimmu.2023.1141408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086240/
https://www.ncbi.nlm.nih.gov/pubmed/37056768
http://dx.doi.org/10.3389/fimmu.2023.1141408

Ejemplares similares